Loading clinical trials...
Loading clinical trials...
Tacrolimus (FK506) P-III Placebo-Controlled Double-Blind Study in Moderate to Severe Refractory Ulcerative Colitis Patients
Conditions
Interventions
tacrolimus
Placebo
Locations
6
Japan
Chubu Region, Japan
Hokkaido Region, Japan
Kansai Region, Japan
Kanto Region, Japan
Kyushu Region, Japan
Shin'etsu Region, Japan
Start Date
September 1, 2006
Primary Completion Date
April 1, 2008
Completion Date
April 1, 2008
Last Updated
August 26, 2014
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Astellas Pharma Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions